1. Foster RG, Kreitzman L. Rhythms of Life: The Biological Clocks that Control the Daily Lives of Every Living Thing. New Haven (Connecticut): Yale University Press; 2005.
5. Reddy P, Zehring WA, Wheeler DA, Pirrotta V, Hadfield C, Hall JC, et al. Molecular analysis of the period locus in Drosophila melanogaster and identification of a transcript involved in biological rhythms. Cell 1984;38:701-710.
7. Crosby EC, Woodburne RT. The mammalian midbrain and isthmus regions. Part II. The fiber connections. C. The hypothalamo-tegmental pathways. J Comp Neurol 1951;94:1-32.
10. Gillette M. Chronobiology: Biological Timing in Health and Disease. Progress in Molecular Biology and Translational Science Vol: 119. Boston: Elsevier; 2013.
11. Dijk DJ, Duffy JF, Czeisler CA. Contribution of circadian physiology and sleep homeostasis to age- related changes in human sleep. Chronobiol Int 2000;17:285-311.
14. Takao T, Tachikawa H, Kawanishi Y, Mizukami K, Asada T. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: a preliminary study. Eur Neuropsychopharmacol 2007;17:273-276.
15. Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, et al. Influence ofCLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003;123B:23-26.
16. Lee KY, Song JY, Kim SH, Kim SC, Joo EJ, Ahn YM, et al. Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder. Prog Neuro-Psychopharmacology Biol Psychiatry 2010;34:1196-1201.
17. Jones SG, Benca RM. Circadian disruption in psychiatric disorders. Sleep Med Clin 2015;10:481-493.
20. Gekakis N, Saez L, Delahaye-Brown AM, Myers MP, Sehgal A, Young MW, et al. Isolation of timeless by PER protein interaction: defective interaction between timeless protein and long-period mutant PERL. Science 1995;270:811-815.
21. Allada R, White NE, So WV, Hall JC, Rosbash M. A mutant drosophila homolog of mammalian clock disrupts circadian rhythms and transcription of period and timeless. Cell 1998;93:791-804.
22. Rutila JE, Suri V, Le M, So WV, Rosbash M, Hall JC. CYCLE Is a second bHLH-PAS clock protein essential for circadian rhythmicity and transcription of drosophila period and timeless. Cell 1998;93:805-814.
23. Price JL, Blau J, Rothenfluh A, Abodeely M, Kloss B, Young MW. Double-time is a novel drosophila clock gene that regulates PERIOD protein accumulation. Cell 1998;94:83-95.
24. Kloss B, Price JL, Saez L, Blau J, Rothenfluh A, Wesley CS, et al. The drosophila clock gene double-time encodes a protein closely related to human casein kinase Iepsilon. Cell 1998;94:97-107.
27. Challet E. Keeping circadian time with hormones. Diabetes Obes Metab 2015;17:76-83.
29. Tsang AH, Astiz M, Friedrichs M, Oster H. Endocrine regulation of circadian physiology. J Endocrinol 2016;230:R1-R11.
30. Mrosovsky N, Hattar S. Impaired masking responses to light in melanopsin‐knockout mice. Chronobiol Int 2003;20:989-999.
31. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010;72:517-549.
32. Pevet P, Challet E. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol 2011;105:170-182.
33. Hankins MW, Peirson SN, Foster RG. Melanopsin: an exciting photopigment. Trends Neurosci 2008;31:27-36.
35. Asher G, Sassone-Corsi P. Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock. Cell 2015;161:84-92.
36. Buijs FN, Cazarez F, Basualdo MC, Scheer FAJL, Perusquía M, Centurion D, et al. The suprachiasmatic nucleus is part of a neural feedback circuit adapting blood pressure response. Neuroscience 2014;266:197-207.
37. Pfeffer M, Wicht H. Synchronizing effects of melatonin on diurnal and circadian rhythms. Gen Comp Endocrinol 2018;258:215-221.
41. Duval F, Mokrani MC, Erb A, Gonzalez opera F, Calleja C, Paris V. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients. Psychoneuroendocrinology 2017;85:100-109.
44. Saetung S, Nimitphong H, Siwasaranond N, Manodpitipong A, Crowley SJ, Hood MM, et al. Eveningness is associated with greater depressive symptoms in type 2 diabetes patients: a study in two different ethnic cohorts. Behav Sleep Med 2019;17:291-301.
50. Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet Part B Neuropsychiatr Genet 2008;147B:1047-1055.
52. Suzuki M, Dallaspezia S, Locatelli C, Lorenzi C, Uchiyama M, Colombo C, et al. CLOCK gene variants associated with the discrepancy between subjective and objective severity in bipolar depression. J Affect Disord 2017;210:14-18.
53. Benedetti F, Riccaboni R, Dallaspezia S, Locatelli C, Smeraldi E, Colombo C. Effects of CLOCK gene variants and early stress on hopelessness and suicide in bipolar depression. Chronobiol Int 2015;32:1156-1161.
57. Mansour HA, Wood J, Logue T, Chowdari KV, Dayal M, Kupfer DJ, et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 2006;5:150-157.
58. Etain B, Jamain S, Milhiet V, Lajnef M, Boudebesse C, Dumaine A, et al. Association between circadian genes, bipolar disorders and chronotypes. Chronobiol Int 2014;31:807-814.
59. Hua P, Liu W, Chen D, Zhao Y, Chen L, Zhang N, et al. Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population. J Affect Disord 2014;157:100-103.
60. Johansson A-S, Owe-Larsson B, Hetta J, Lundkvist GB. Altered circadian clock gene expression in patients with schizophrenia. Schizophr Res 2016;174:17-23.
63. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 2004;77:858-866.
64. Sun HQ, Li SX, Chen FB, Zhang Y, Li P, Jin M, et al. Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients. Psychoneuroendocrinology 2016;64:108-116.
66. Lavebratt C, Sjöholm LK, Partonen T, Schalling M, Forsell Y. PER2 variantion is associated with depression vulnerability. Am J Med Genet Part B Neuropsychiatr Genet 2010;153:570-581.
67. Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 2007;39:229-238.
68. Liu JJ, Sudic Hukic D, Forsell Y, Schalling M, Ösby U, Lavebratt C. Depression-associated ARNTL and PER2 genetic variants in psychotic disorders. Chronobiol Int 2015;32:579-584.
69. Artioli P, Lorenzi C, Pirovano A, Serretti A, Benedetti F, Catalano M, et al. How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes. Eur Neuropsychopharmacol 2007;17:587-594.
72. Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet Part B Neuropsychiatr Genet 2006;141B:234-241.
73. Benedetti F, Dallaspezia S, Colombo C, Pirovano A, Marino E, Smeraldi E. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett 2008;445:184-187.
74. Dallaspezia S, Lorenzi C, Pirovano A, Colombo C, Smeraldi E, Benedetti F. Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder. Eur Psychiatry 2011;26:138-140.
75. Karthikeyan R, Marimuthu G, Ramasubramanian C, Arunachal G, BaHammam AS, Spence DW, et al. Association of Per3 length polymorphism with bipolar I disorder and schizophrenia. Neuropsychiatr Dis Treat 2014;10:2325-2330.
76. Bengesser SA, Reininghaus EZ, Lackner N, Birner A, Fellendorf FT, Platzer M, et al. Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL. World J Biol Psychiatry 2018;19:S21-S29.
77. Sipilä T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry 2010;67:1163-1170.
78. Byrne EM, Heath AC, Madden PAF, Pergadia ML, Hickie IB, Montgomery GW, et al. Testing the role of circadian genes in conferring risk for psychiatric disorders. Am J Med Genet Part B Neuropsychiatr Genet 2014;165:254-260.
79. Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R, et al. Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBα gene, a critical component of the circadian clock system. Bipolar Disord 2009;11:215-220.
80. Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, et al. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci Res 2008;62:211-215.
81. Geoffroy PA, Etain B, Lajnef M, Zerdazi E-H, Brichant-Petitjean C, Heilbronner U, et al. Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1 α) and RORA. Genes Brain Behav 2016;15:660-668.
84. Gałecki P, Szemraj J, Bartosz G, Bieńkiewicz M, Gałecka E, Florkowski A, et al. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder. J Pineal Res 2010;48:311-317.
86. Geoffroy PA, Boudebesse C, Henrion A, Jamain S, Henry C, Leboyer M, et al. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study. Genes Brain Behav 2014;13:299-304.
88. Gałecka E, Szemraj J, Florkowski A, Gałecki P, Bieńkiewicz M, Karbownik-Lewińska M, et al. Single nucleotide polymorphisms and mRNA expression for melatonin MT2 receptor in depression. Psychiatry Res 2011;189:472-474.
89. Lee KY, Ahn YM, Kim SH, Kang HG, Joo EJ. Genetic association study of CSNK1E gene in bipolar disorder and circadian characteristics. Nord J Psychiatry 2018;72:599-604.
90. Matsunaga S, Ikeda M, Kishi T, Fukuo Y, Aleksic B, Yoshimura R, et al. An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders. Neurosci Lett 2012;529:66-69.
91. Pinacho R, Villalmanzo N, Meana JJ, Ferrer I, Berengueras A, Haro JM, et al. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 2016;177:88-97.
93. Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska-Rodziewicz A, Kapelski P, et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 2006;53:51-56.
94. Guilding C, Piggins HD. Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur J Neurosci 2007;25:3195-3216.
95. Kalsbeek A, Palm IF, La Fleur SE, Scheer FAJL, Perreau-Lenz S, Ruiter M, et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms 2006;21:458-469.
96. Ono T, Nishino H, Sasaka K, Muramoto K, Yano I, Simpson A. Paraventricular nucleus connections to spinal cord and pituitary. Neurosci Lett 1978;10:141-146.
97. la Fleur SE, Kalsbeek A, Wortel J, Buijs RM. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res 2000;871:50-56.
99. la Fleur SE, Kalsbeek A, Wortel J, Fekkes ML, Buijs RM. A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus. Diabetes 2001;50:1237-1243.
100. Buijs RM, Guzmán Ruiz MA, Méndez Hernández R, Rodríguez Cortés B. The suprachiasmatic nucleus; a responsive clock regulating homeostasis by daily changing the setpoints of physiological parameters. Auton Neurosci 2019;218:43-50.
101. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002;87:240-244.
103. Kalsbeek A, van der Spek R, Lei J, Endert E, Buijs RM, Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol Cell Endocrinol 2012;349:20-29.
104. Van De Kar LD, Lorens SA. Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei. Brain Res 1979;162:45-54.
106. Buijs FN, León-Mercado L, Guzmán-Ruiz M, Guerrero-Vargas NN, Romo-Nava F, Buijs RM. The circadian system: a regulatory feedback network of periphery and brain. Physiology 2016;31:170-181.
107. Pontes ALB de, Engelberth RCGJ, Nascimento E da S, Cavalcante JC, Costa MSM de O, Pinato L, et al. Serotonin and circadian rhythms. Psychol Neurosci 2010;3:217-228.
109. Pévet P. Melatonin: from seasonal to circadian signal. J Neuroendocrinol 2003;15:422-426.
111. Cagnacci A, Elliott JA, Yen SS. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab 1992;75:447-452.
113. Kalsbeek A, Cutrera R, van Heerikhuize J, van der Vliet J, Buijs R. GABA release from suprachiasmatic nucleus terminals is necessary for the light-induced inhibition of nocturnal melatonin release in the rat. Neuroscience 1999;91:453-461.
114. Khaldy H, León J, Escames G, Bikjdaouene L, García JJ, Acuña-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 2002;75:201-208.
116. Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004;25:177-195.
117. Burton R. The Natomy of Melancholy. London: Oxford University Press; 1621.
118. Richter CP. Biological Clocks in Medicine and Psychiatry. Springfield, Illinois: Charles C. Thomas; 1965.
119. Souêtre E, Salvati E, Belugou J-L, Pringuey D, Candito M, Krebs B, et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989;28:263-278.
120. Atkinson M, Kripke DF, Wolf SR. Autorhythmometry in manic-depressives. Chronobiologia 1975;2:325-335.
123. Zung WWK, Green RL. Seasonal variation of suicide and depression. Arch Gen Psychiatry 1974;30:89-91.
124. Milstein V, Small JG, Shelbourne D, Small IF. Manic depressive illness: onset, diurnal temperature and season of birth. Dis Nerv Syst 1976;37:373-375.
125. Eastwood MR, Peacocke J. Seasonal patterns of suicide, depression and electroconvulsive therapy. Br J Psychiatry 1976;129:472-475.
126. Frangos E, Athanassenas G, Tsitourides S, Psilolignos P, Robos A, Katsanou N, et al. Seasonality of the episodes of recurrent affective psychoses: possible prophylactic interventions. J Affect Disord 1980;2:239-247.
127. Berkol TD, Seren Kirlioğlu S, Balcioğlu YH, Üstün N, İslam S, Özyildirim İ. Comparison of sociodemographic and clinical characteristics of bipolar patients with and without seasonal patterns. Anadolu Psikiyatr Derg 2017;18.
128. Faedda GL, Tondo L, Teicher MH, Baldessarini RJ, Gelbard HA, Floris GF. Seasonal mood disorders: patterns of seasonal recurrence in mania and depression. Arch Gen Psychiatry 1993;50:17-23.
129. Iasevoli F, Avvisati L, Gilardi V, Latte G, Prinzivalli E, de Berardis D, et al. Chronobiology of Mood Disorders. In: López-Muñoz F, Srinivasan V, de Berardis D, Álamo C, Kato T, editor. Melatonin, Neuroprotective Agents and Antidepressant Therapy. New Delhi: Springer, 2016, p. 273-295.
131. Wehr TA, Sack D, Rosenthal N, Duncan W, Gillin JC. Circadian rhythm disturbances in manic-depressive illness. Fed Proc 1983;42:2809-2814.
132. Wirz-Justice A, Pühringer W, Hole G. Sleep deprivation and clomipramine in endogenous depression. Lancet 1976;308:912
133. Wirz-Justice A, Tobler I, Kafka MS, Naber D, Marangos PJ, Borbély AA, et al. Sleep deprivation: effects on circadian rhythms of rat brain neurotransmitter receptors. Psychiatry Res 1981;5:67-76.
134. Simon RD. Shift work disorder: clinical assessment and treatment strategies. J Clin Psychiatry 2012;73:e20
135. Vargas I, Garland SN, Kloss JD, Perlis ML. Insomnia and psychiatric disorders. Sleep Heal 2019;373-389.
136. Vadnie CA, McClung CA. Circadian rhythm disturbances in mood disorders: insights into the role of the suprachiasmatic nucleus. Neural Plast 2017;2017:1-28.
137. Stubbs B, Wu Y-T, Prina AM, Leng Y, Cosco TD. A population study of the association between sleep disturbance and suicidal behaviour in people with mental illness. J Psychiatr Res 2016;82:149-154.
138. Monteleone P, Maj M. The circadian basis of mood disorders: Recent developments and treatment implications. Eur Neuropsychopharmacol 2008;18:701-711.
140. Kupfer DJ, Foster FG. Interval between onset of sleep and rapid-eyemovement sleep as an indicator of depression. Lancet 1972;300:684-686.
141. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski V, Doman J, et al. Application of automated REM and slow wave sleep analysis: II. Testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatry Res 1984;13:335-343.
142. Rush AJ, Erman MK, Giles DE, Schlesser MA, Carpenter G, Vasavada N, et al. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 1986;43:878-884.
143. Giles DE, Jarrett RB, Roffwarg HP, Rush AJ. Reduced rapid eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacology 1987;1:33-39.
144. Pillai V, Kalmbach DA, Ciesla JA. A meta-analysis of electroencephalographic sleep in depression: evidence for genetic biomarkers. Biol Psychiatry 2011;70:912-919.
145. Rotenberg VS, Shamir E, Barak Y, Indursky P, Kayumov L, Mark M. REM sleep latency and wakefulness in the first sleep cycle as markers of major depression: a controlled study vs. schizophrenia and normal controls. Prog Neuro-Psychopharmacology Biol Psychiatry 2002;26:1211-1215.
146. Steiger A, Kimura M. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res 2010;44:242-252.
147. Monteleone P, Martiadis V, Maj M. Circadian rhythms and treatment implications in depression. Prog Neuro-Psychopharmacology Biol Psychiatry 2011;35:1569-1574.
148. De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, et al. The role of melatonin in mood disorders. ChronoPhysiology Ther 2015;5:65-75.
149. Emens J, Lewy A, Kinzie JM, Arntz D, Rough J. Circadian misalignment in major depressive disorder. Psychiatry Res 2009;168:259-261.
150. Shafii M, MacMillan DR, Key MP, Derrick AM, Kaufman N, Nahinsky ID. Nocturnal serum melatonin profile in major depression in children and adolescents. Arch Gen Psychiatry 1996;53:1009-1013.
152. Cagnacci A, Kräuchi K, Wirz-Justice A, Volpe A. Homeostatic versus circadian effects of melatonin on core body temperature in humans. J Biol Rhythms 1997;12:509-517.
153. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006;21:S11-S15.
154. Kennaway DJ. Clock genes at the heart of depression. J Psychopharmacol 2010;24:5-14.
155. Etain B, Milhiet V, Bellivier F, Leboyer M. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol 2011;21:S676-S682.
156. Melhuish Beaupre L, Brown GM, Kennedy JL. Circadian genes in major depressive disorder. World J Biol Psychiatry 2020;21:80-90.
157. Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, et al. Do corticosteroids damage the brain? J Neuroendocrinol 2006;18:393-411.
162. Goodyer IM, Herbert J, Altham PME. Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med 1998;28:265-273.
163. Gallagher P, Young A. Cortisol/DHEA ratios in depression [2]. Neuropsychopharmacology 2002;26:410
164. Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ. The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 2009;34:19-26.
165. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008;31:464-468.
168. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010;197:372-377.
169. Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev 2015;14:30-35.
173. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, Sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 2016;80:40-52.
174. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008;165:830-843.
175. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008;165:820-829.
176. Dallaspezia S, Benedetti F. Sleep in Other Psychiatric Disorders. In: Chokroverty S, Ferini-Strambi L, editor. Oxford Textbook of Sleep Disorders. Oxford: Oxford University Press, 2017, p. 451
177. Rocha PMB, Neves FS, Corrêa H. Significant sleep disturbances in euthymic bipolar patients. Compr Psychiatry 2013;54:1003-1008.
178. Geoffroy PA, Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, et al. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand 2015;131:89-99.
179. Kaplan KA, McGlinchey EL, Soehner A, Gershon A, Talbot LS, Eidelman P, et al. Hypersomnia subtypes, sleep and relapse in bipolar disorder. Psychol Med 2015;45:1751-1763.
180. Boudebesse C, Geoffroy PA, Bellivier F, Henry C, Folkard S, Leboyer M, et al. Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder. Chronobiol Int 2014;31:698-704.
181. Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, et al. Sleep disturbance may impact treatment outcome in bipolar disorder: a preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord 2018;225:563-568.
183. Kanady JC, Soehnera AM, Harvey AG. A Retrospective examination of sleep disturbance across the course of bipolar disorder. J Sleep Disord Ther 2015;4:1000193
184. Ng TH, Chung KF, Ho FY, Yeung WF, Yung KP, Lam TH. Sleep-wake disturbance in interepisode bipolar disorder and high-risk individuals: a systematic review and meta-analysis. Sleep Med Rev 2015;20:46-58.
185. Robillard R, Naismith SL, Rogers NL, Scott EM, Ip TKC, Hermens DF, et al. Sleep-Wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry 2013;28:412-416.
186. Nováková M, Praško J, Látalová K, Sládek M, Sumová A. The circadian system of patients with bipolar disorder differs in episodes of mania and depression. Bipolar Disord 2015;17:303-314.
187. Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol “switches” during mania, depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis 1989;177:300-303.
188. Lewy AJ, Wehr TA, Gold PW, Goodwin FK. Plasma melatonin in manic-depressive illness. Catech Basic Clin Front 1979;1173-1175.
189. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Rosenthal NE. Manic-depressive patients may be supersensitive to light. Lancet 1981;317:383-384.
190. Livianos L, Sierra P, Arques S, García A, Rojo L. Is melatonin an adjunctive stabilizer? Psychiatry Clin Neurosci 2012;66:82-83.
191. Geoffroy PA. Clock genes and light signaling alterations in bipolar disorder: when the biological clock is off. Biol Psychiatry 2018;84:775-777.
192. McCarthy MJ, Welsh DK. Cellular circadian clocks in mood disorders. J Biol Rhythms 2012;27:339-352.
196. Parekh PK, Becker-Krail D, Sundaravelu P, Ishigaki S, Okado H, Sobue G, et al. Altered GluA1 (Gria1) function and accumbal synaptic plasticity in the ClockΔ19 model of bipolar mania. Biol Psychiatry 2018;84:817-826.
197. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-1569.
198. Pawlak J, Dmitrzak-Weglarz M, Maciukiewicz M, Wilkosc M, Leszczynska-Rodziewicz A, Zaremba D, et al. Suicidal behavior in the context of disrupted rhythmicity in bipolar disorder- Data from an association study of suicide attempts with clock genes. Psychiatry Res 2015;226:517-520.
199. Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, et al. The HPA axis in bipolar disorder: systematic review and metaanalysis. Psychoneuroendocrinology 2016;63:327-342.
200. Sigitova E, Fišar Z, Hroudová J, Cikánková T, Raboch J. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci 2017;71:77-103.
201. Girshkin L, Matheson SL, Shepherd AM, Green MJ. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 2014;49:187-206.
202. Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 2013;74:15-25.
203. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’Anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009;116:214-217.
204. Bai YM, Su TP, Li CT, Tsai SJ, Chen MH, Tu PC, et al. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord 2015;17:269-277.
205. Peirson SN, Foster RG. Sleep and Circadian Rhythm Disruption in Psychosis. In: Colwell CS, editor. Circadian Medicine. New York: Wiley-Blackwell, 2015, p. 271-282.
208. Yates NJ. Schizophrenia: the role of sleep and circadian rhythms in regulating dopamine and psychosis. Rev Neurosci 2016;27:669-687.
209. Monti JM, BaHammam AS, Pandi-Perumal SR, Bromundt V, Spence DW, Cardinali DP, et al. Sleep and circadian rhythm dysregulation in schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry 2013;43:209-216.
213. Lamont EW, Coutu DL, Cermakian N, Boivin DB. Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Relat Sci 2010;47:27-35.
214. Cosgrave J, Wulff K, Gehrman P. Sleep, circadian rhythms, and schizophrenia. Curr Opin Psychiatry 2018;31:176-182.
215. Sasidharan A, Kumar S, Nair AK, Lukose A, Marigowda V, John JP, et al. Further evidences for sleep instability and impaired spindle-delta dynamics in schizophrenia: a whole-night polysomnography study with neuroloop-gain and sleep-cycle analysis. Sleep Med 2017;38:1-13.
216. Chan MS, Chung KF, Yung KP, Yeung WF. Sleep in schizophrenia: a systematic review and meta-analysis of polysomnographic findings in case-control studies. Sleep Med Rev 2017;32:69-84.
217. Kaskie RE, Gill KM, Ferrarelli F. Reduced frontal slow wave density during sleep in first-episode psychosis. Schizophr Res 2019;206:318-324.
218. Bian Y, Liang W, Yue W, Han X, Lin C, Zhang J, et al. Meta-analysis of sleep structure in patients with untreated schizophrenia. Chinese Ment Heal J 2017;31:208-214.
221. Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 2009;47:82-96.
222. Galván-Arrieta T, Trueta C, Cercós MG, Valdés-Tovar M, Alarcón S, Oikawa J, et al. The role of melatonin in the neurodevelopmental etiology of schizophrenia: A study in human olfactory neuronal precursors. J Pineal Res 2017;63:e12421
223. Rao ML, Gross G, Strebel B, Halaris A, Huber G, Bräunig P, et al. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151-163.
224. Sandyk R, Kay SR. The relationship of pineal calcification to cortical atrophy in schizophrenia. Int J Neurosci 1991;57:179-191.
225. Witkovsky P. Dopamine and retinal function. Doc Ophthalmol 2004;108:17-39.
226. Tardito D, Milanese M, Bonifacino T, Musazzi L, Grilli M, Mallei A, et al. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2Creceptor-dependent pathways. BMC Neurosci 2010;11:1-4.
227. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of γ-aminobutyric acid and glutamate alterations. Arch Neurol 2006;63:1372-1376.
228. Gorfine T, Assaf Y, Goshen-Gottstein Y, Yeshurun Y, Zisapel N. Sleep-anticipating effects of melatonin in the human brain. Neuroimage 2006;31:410-418.
229. Shamir E, Barak Y, Shalman I, Laudon M, Zisapel N, Tarrasch R, et al. Melatonin Treatment for Tardive Dyskinesia. Arch Gen Psychiatry 2001;58:1049-1052.
230. Onaolapo AY, Aina OA, Onaolapo OJ. Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia. Biomed Pharmacother 2017;92:373-383.
232. Coulon N, Brailly-Tabard S, Walter M, Tordjman S. Altered circadian patterns of salivary cortisol in individuals with schizophrenia: a critical literature review. J Physiol 2016;110:439-447.
233. Singh M, Solanki RK, Bagaria B, Swami MK. Hypothalamic-Pituitary-Adrenal (HPA) axis functioning among patients with schizophrenia: a cross sectional comparative study. J Psychiatry (South Africa) 2015;18:1000211
236. Bradley AJ, Dinan TG. Review: a systematic review of hypothalamic pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 2010;24:91-118.
237. Zorn J V, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis. Psychoneuroendocrinology 2017;77:25-36.
239. Boland EM, Ross RJ. Recent advances in the study of sleep in the anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder. Psychiatr Clin North Am 2015;38:761-776.
240. Cox RC, Olatunji BO. A systematic review of sleep disturbance in anxiety and related disorders. J Anxiety Disord 2016;37:104-129.
242. Brown TM, Black B, Uhde TW. The sleep architecture of social phobia. Biol Psychiatry 1994;35:420-421.
243. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th Ed.Washington, D.C: American Psychiatric Pub; 2013.
245. Kupfer D, Foster FG. Interval between onset of sleep and rapid-eyemovement sleep as an indicator of depression. Lancet 1972;300:684-686.
246. Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry 1976;11:159-174.
247. Sitaram N, Nurnberger JI, Gershon ES, Gillin JC. Cholinergic regulation of mood and REM sleep: Potential model and marker of vulnerability to affective disorder. Am J Psychiatry 1982;139:571-576.
248. Millar A, Espie CA, Scott J. The sleep of remitted bipolar outpatients: a controlled naturalistic study using actigraphy. J Affect Disord 2004;80:145-153.
249. Hudson JI, Lipinski JF, Keck PE, Aizley HG, Lukas SE, Rothschild AJ, et al. Polysomnographic characteristics of young manic patients: comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry 1992;49:378-383.
250. Linkowski P, Mendlewicz J. Sleep electroencephalogram and rhythm disturbances in mood disorders. Curr Opin Psychiatry 1993;6:35-37.
251. Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ. Electroencephalographic sleep in mania. Arch Gen Psychiatry 1988;45:267-273.
252. Gillin JC, Duncan W, Pettigrew KD, Frankel BL, Snyder F. Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 1979;36:85-90.
254. Giles DE, Rush AJ, Roffwarg HP. Sleep parameters in bipolar I, bipolar II, and unipolar depressions. Biol Psychiatry 1986;21:1340-1343.
255. Fossion P, Staner L, Dramaix M, Kempenaers C, Kerkhofs M, Hubain P, et al. Does sleep EEG data distinguish between UP, BPI or BPII major depressions? An age and gender controlled study. J Affect Disord 1998;49:181-187.
256. Jernajczyk W. Latency of eye movement and other REM sleep parameters in bipolar depression. Biol Psychiatry 1986;21:465-472.
257. Bian Y, Liang WY, Yue WH, Han XL, Lin C, Zhang J, et al. Sleep architecture in drug naive patients with schizophrenia: a meta-analysis. Chinese Ment Heal J 2017;31:208-214.
258. Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 1997;154:1497-1503.
259. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 2006;60:275-281.
260. Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF. Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 2001;158:1612-1616.
263. Wetterberg L. Clinical importance of melatonin. Prog Brain Res 1979;52:539-547.
264. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984;19:1215-1228.
265. Parry BL, Newton RP. Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 2001;25:S102-S108.
266. Beck‐Friis J, Kjellman BF, Aperia B, Unden F, von Rosen D, Ljunggren JG, et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand 1985;71:319-330.
267. Nair NPV, Hariharasubramanian N, Pilapil C. Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry 1984;8:715-718.
268. Brown R, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes PE, et al. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 1985;142:811-816.
269. Frazer A, Brown R, Kocsis J, Caroff S, Amsterdam J, Winokur A, et al. Patterns of melatonin rhythms in depression. J Neural Transm Suppl 1986;21:269-290.
270. Fountoulakis KN, Karamouzis M, Iacovides A, Nimatoudis J, Diakogiannis J, Kaprinis G, et al. Morning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40-41.5°). Neuropsychobiology 2001;44:113-117.
271. Paparrigopoulos T. Melatonin response to atenolol administration in depression: indication of β-adrenoceptor dysfunction in a subtype of depression. Acta Psychiatr Scand 2002;106:440-445.
272. Wehr TA, Sack DA, Duncan WC, Mendelson WB, Rosenthal NE, Gillin JC, et al. Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Res 1985;15:327-339.
273. Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depression - A potential biomarker? J Psychiatr Res 2010;44:69-74.
275. Crasson M, Kjiri S, Colin A, Kjiri K, L’Hermite-Baleriaux M, Ansseau M, et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology 2004;29:1-12.
276. Tuunainen A, Kripke DF, Elliott JA, Assmus JD, Rex KM, Klauber MR, et al. Depression and endogenous melatonin in postmenopausal women. J Affect Disord 2002;69:149-158.
278. Beck-Friis J, von Rosen D, Kjellman BF, Ljunggren JG, Wetterberg L. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 1984;9:261-277.
279. Kennedy SH, Kutcher SP, Ralevski E, Brown GM. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 1996;63:219-222.
280. Monteleone P, Natale M, La Rocca A, Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: No change after subchronic treatment with antipsychotics. Neuropsychobiology 1997;36:159-163.
281. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 1992;7:77-84.
282. Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M. Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia. Neuroendocrinol Lett 2003;24:181-184.